INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-2 AND PROTEIN-3 STIMULATE GROWTH-HORMONE RECEPTOR-BINDING AND MITOGENESIS IN RAT OSTEOSARCOMA CELLS

被引:60
|
作者
SLOOTWEG, MC
OHLSSON, C
SALLES, JP
DEVRIES, CP
NETELENBOS, JC
机构
[1] FREE UNIV AMSTERDAM HOSP,RES INST ENDOCRINOL,1007 MB AMSTERDAM,NETHERLANDS
[2] SAHLGRENS UNIV HOSP,ENDOCRINOL & METAB RES CTR,S-41345 GOTHENBURG,SWEDEN
关键词
D O I
10.1210/en.136.10.4210
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GH exerts its biological actions an osteoblasts through a specific high affinity receptor expressed on these cells. GH receptor binding is positively modulated by a number of factors, including retinoic acid and dexamethasone, whereas fetal calf serum strongly decreases the binding. To identify responsible factors in serum, components of serum, the insulin-like growth factors (IGFs)-I and -II, and IGF binding proteins (IGFBPs)-2 and -3 were tested for a possible negative modulatory role. IGF-I and -II decreased [I-125]hGH binding at an optimal concentration of 30 ng/ml for IGF-I and 100 ng/ml IGF-II, reducing the binding to 51% and 55%, respectively, of control values. A stimulation of [I-125]hGH binding was observed with IGFBP-2 as well as IGFBP-3, inducing an increase to 148% and 151% of control binding at an optimal concentration of 3000 ng/ml for both peptides. The effects of all peptides were dependent on the incubation time, being significantly increased after 8 h of incubation and reaching the full effect thereafter. The effects were declined at 24 h compared with 16 h for IGFBP-2 and -3 but not for IGF-I and -II. Coincubation of the cells with TGF-I and -II and IGFBP-2 and -3 neutralized the effects of the factors alone. In conclusion, these results show that IGF-I and -II on the one hand and IGFBP-2 and -3 on the other hand exert opposite actions on [I-125]hGH binding, IGFBP-5 and -3 exerting probably an IGF-independent effect. Further, IGF-I and -II decreased GH receptor messenger RNA (mRNA) levels, as quantified by a solution hybridization ribonuclease protection assay, from 8.65 +/- 1.78 attomoles (amol)/mu g DNA (control) to 2.4 +/- 0.68 and 2.16 +/- 0.92 amol/mu g DNA, respectively. IGFBP-5 increased GH receptor mRNA levels from 5.26 +/- 1.17 (control) to 18.19 +/- 3.48. Incubation with IGFBP-3 did not result in stimulation of GH receptor mRNA levels (8.59 +/- 2.91 amol/mu g DNA). This shows that the mechanism of regulation of the GH receptor is, except for IGFBP-3, at least in part on the mRNA level. Lastly, IGFBP-2 and IGFBP-3 are mitogenic for UMR-106.01 rat osteosarcoma cells, inducing an increase in cell number to 125% and 142% of control cell counts after 48 h of incubation with 1000 ng/ml IGFBP-2 and -3, whereas IGF-I, IGF-II and Long R(3) IGF-I did not stimulate proliferation. IGFBP-2 and -3 potentiate hGH induced mitogenesis at low hGH concentrations of both factors, whereas at higher concentrations no such effect is observed. IGF-I and -II inhibit hGHs action. The physiological relevance of GH receptor modulation is a subject of investigation at the present time.
引用
收藏
页码:4210 / 4217
页数:8
相关论文
共 50 条
  • [41] Insulin-Like Growth Factor Binding Protein-3 Binds to Histone 3
    Bhardwaj, Apurva
    Pathak, Kumar Alok
    Shrivastav, Anuraag
    Varma Shrivastav, Shailly
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (01) : 1 - 11
  • [42] GROWTH-HORMONE SUPPRESSION OF APOPTOSIS IN PREOVULATORY RAT FOLLICLES AND PARTIAL NEUTRALIZATION BY INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN
    EISENHAUER, KM
    CHUN, SY
    BILLIG, H
    HSUEH, AJW
    BIOLOGY OF REPRODUCTION, 1995, 53 (01) : 13 - 20
  • [43] PROTEOLYSIS OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 DURING RAT PREGNANCY - A ROLE FOR MATRIX METALLOPROTEINASES
    FOWLKES, JL
    SUZUKI, K
    NAGASE, H
    THRAILKILL, KM
    ENDOCRINOLOGY, 1994, 135 (06) : 2810 - 2813
  • [44] EVALUATION OF PLASMA INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 AS A POTENTIAL PREDICTOR OF PREECLAMPSIA
    VARMA, M
    DEGROOT, CJM
    LANYI, S
    TAYLOR, RN
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1993, 169 (04) : 995 - 999
  • [45] RADIOIMMUNOASSAY OF GROWTH-HORMONE DEPENDENT INSULIN-LIKE GROWTH-FACTOR BINDING-PROTEIN IN HUMAN-PLASMA
    BAXTER, RC
    MARTIN, JL
    JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (06): : 1504 - 1512
  • [46] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 SECRETION FROM CULTURED RAT SERTOLI CELLS - DUAL REGULATION BY FOLLICLE-STIMULATING-HORMONE AND INSULIN-LIKE GROWTH FACTOR-I
    SMITH, EP
    DICKSON, BA
    CHERNAUSEK, SD
    ENDOCRINOLOGY, 1990, 127 (06) : 2744 - 2751
  • [47] EFFECTS OF OVARIECTOMY AND ESTROGEN ON THE SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR-I AND INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3
    KALU, DN
    ARJMANDI, BH
    LIU, CC
    SALIH, MA
    BIRNBAUM, RS
    BONE AND MINERAL, 1994, 25 (02): : 135 - 148
  • [48] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IS PRESENT IN THE ALPHA-GRANULES OF PLATELETS
    SPENCER, EM
    TOKUNAGA, A
    HUNT, TK
    ENDOCRINOLOGY, 1993, 132 (03) : 996 - 1001
  • [49] INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 IS OVEREXPRESSED IN SENESCENT AND QUIESCENT HUMAN FIBROBLASTS
    MOERMAN, EJ
    THWEATT, R
    MOERMAN, AM
    JONES, RA
    GOLDSTEIN, S
    EXPERIMENTAL GERONTOLOGY, 1993, 28 (4-5) : 361 - 370
  • [50] Evidence of insulin-like growth factor binding protein-3 proteolysis during growth hormone stimulation testing
    Nwosu, Benjamin U.
    Soyka, Leslie A.
    Angelescu, Amanda
    Lee, Mary M.
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2011, 24 (3-4): : 163 - 167